Global Health Policy

  • Your Selections:

Refine Results

date

Topics

Content Type

Tags

What Could the U.S. Do to Help Improve Global COVID-19 Vaccine Equity?

As India and other countries continue to grapple with major COVID-19 outbreaks even as cases decline in this country, there is increasing attention to the global role that could be played by the U.S. government.  This is particularly the case now that the U.S. will soon have enough COVID-19 vaccine…

Global COVID-19 Vaccine Equity: U.S. Policy Options and Actions to Date

This brief examines U.S. policy options for helping expand global access to COVID-19 vaccines, focusing on four main areas: in-kind donations of vaccine doses, additional funding for global access mechanisms like COVAX, helping expand global vaccine manufacturing, and relaxing or waiving intellectual property protections on vaccine technologies. We summarize what the administration has done to date in these areas and policy issues related to each.

U.S. Global Health Budget Tracker

This tracker provides regularly updated information on U.S. government funding for global health. It includes historical trends and tracks funding levels throughout the appropriations process. Data can be customized by fiscal year, sector, and U.S. agency. 

Global COVID-19 Vaccine Access: A Snapshot of Inequality

This policy watch examines global access to COVID-19 vaccines by country income level, assessing country income levels’ shares of purchased doses and potential vaccination coverage, while also looking closely at the potential impact of COVAX in addressing vaccine access disparity between high-income and low- and middle-income countries.

The Global HIV/AIDS Epidemic

This updated fact sheet provides the latest data on the global HIV/AIDS epidemic, including impact by region, treatment and prevention efforts, and an overview of the U.S. and global responses to the epidemic.

Many Nonelderly People With Disabilities Face COVID-19 Risks Similar to Those of the Elderly in Nursing Homes, But Do Not Have Equal Footing When it Comes to Vaccine Priority

While the toll of COVID-19 on nursing home residents has been well documented, less noticed has been the experience of nonelderly people with disabilities who rely on long-term care services and supports outside of nursing homes. In many ways the two groups face similar health risks from the virus, but…

COVAX and the United States

This issue brief provides an overview of COVAX, the global mechanism to secure and deliver COVID-19 vaccines. The brief details COVAX’s organization, conditions for country participation, activities, and financing structure. Additionally, it looks at the history and remaining key issues of U.S. engagement with COVAX.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.